Methods of use of G-CSF cysteine muteins

Details Methods of use of G-CSF cysteine muteins Methods of use of G-CSF cysteine muteins

2011-08-09

2011-08-09

Stoica, Elly-Gerald (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S198100, C514S003200

Reexamination Certificate

active

07994124

ABSTRACT:
The present invention relates to therapeutic methods for a protecting an animal from a disease or condition that can be treated by granulocyte colony-stimulating factor (G-CSF) wherein a composition comprising a cysteine variant of G-CSF is provided. Also disclosed herein are preferred cysteine variants of G-CSF for use in the composition.

REFERENCES:
patent: 4588585 (1986-05-01), Mark et al.
patent: 4636463 (1987-01-01), Altman et al.
patent: 4678751 (1987-07-01), Goeddel
patent: 4738844 (1988-04-01), Bell et al.
patent: 4751077 (1988-06-01), Bell et al.
patent: 4810643 (1989-03-01), Souza
patent: 4855238 (1989-08-01), Gray et al.
patent: 4904584 (1990-02-01), Shaw
patent: 4921699 (1990-05-01), DeChiara et al.
patent: 4929554 (1990-05-01), Goeddel et al.
patent: 5096705 (1992-03-01), Goeddel et al.
patent: 5153265 (1992-10-01), Shadle et al.
patent: 5162111 (1992-11-01), Grabstein et al.
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5178855 (1993-01-01), Bonnem
patent: 5206344 (1993-04-01), Katre et al.
patent: 5208158 (1993-05-01), Bech et al.
patent: 5214132 (1993-05-01), Kuga et al.
patent: 5223407 (1993-06-01), Wong et al.
patent: 5229496 (1993-07-01), Deeley et al.
patent: 5382657 (1995-01-01), Karasiewicz et al.
patent: 5391485 (1995-02-01), Deeley et al.
patent: 5393870 (1995-02-01), Deeley et al.
patent: 5441734 (1995-08-01), Reichert et al.
patent: 5574137 (1996-11-01), Gray et al.
patent: 5578301 (1996-11-01), Myers
patent: 5582824 (1996-12-01), Goeddel et al.
patent: 5595888 (1997-01-01), Gray et al.
patent: 5602007 (1997-02-01), Dunn et al.
patent: 5629283 (1997-05-01), Nicola et al.
patent: 5681720 (1997-10-01), Kuga et al.
patent: 5690925 (1997-11-01), Gray et al.
patent: 5720952 (1998-02-01), Clark et al.
patent: 5766897 (1998-06-01), Braxton
patent: 5824778 (1998-10-01), Ishikawa et al.
patent: 5824784 (1998-10-01), Kinstler et al.
patent: 5849535 (1998-12-01), Cunningham et al.
patent: 5891429 (1999-04-01), Clark et al.
patent: 5895646 (1999-04-01), Wang
patent: 5908621 (1999-06-01), Glue et al.
patent: 5908763 (1999-06-01), Clark et al.
patent: 5916773 (1999-06-01), Mele et al.
patent: 5942221 (1999-08-01), Clark et al.
patent: 6042822 (2000-03-01), Gilbert et al.
patent: 6171824 (2001-01-01), Todaro et al.
patent: 6177074 (2001-01-01), Glue et al.
patent: 6250469 (2001-06-01), Kline
patent: 6287557 (2001-09-01), Boursnell et al.
patent: 6323006 (2001-11-01), Peregrino Ferreira et al.
patent: 6362162 (2002-03-01), Rybak et al.
patent: 6461605 (2002-10-01), Cutler et al.
patent: 6472373 (2002-10-01), Albrecht
patent: 6497871 (2002-12-01), Gray et al.
patent: 6514729 (2003-02-01), Bentzien
patent: 6524570 (2003-02-01), Glue et al.
patent: 6531122 (2003-03-01), Pedersen et al.
patent: 6608183 (2003-08-01), Cox, III
patent: 6632426 (2003-10-01), Osslund
patent: 6753165 (2004-06-01), Cox et al.
patent: 6780613 (2004-08-01), Wells et al.
patent: 6800740 (2004-10-01), Cunningham et al.
patent: 7038015 (2006-05-01), Jensen
patent: 7148333 (2006-12-01), Cox, III
patent: 7153943 (2006-12-01), Cox, III et al.
patent: 7214779 (2007-05-01), Cox, III
patent: 7232885 (2007-06-01), Cox, III
patent: 7253267 (2007-08-01), Cox, III
patent: 7270809 (2007-09-01), Cox, III
patent: 7306931 (2007-12-01), Rosendahl et al.
patent: 7309781 (2007-12-01), Cox, III
patent: 7314921 (2008-01-01), Cox, III
patent: 7345149 (2008-03-01), Cox, III
patent: 7345154 (2008-03-01), Cox, III
patent: 7399839 (2008-07-01), Cox et al.
patent: 7495087 (2009-02-01), Cox, III
patent: 7629314 (2009-12-01), Cox, III
patent: 2003/0166865 (2003-09-01), Cox, III
patent: 2004/0136955 (2004-07-01), Barker et al.
patent: 2004/0230040 (2004-11-01), Cox, III
patent: 2005/0214254 (2005-09-01), Cox, III
patent: 2007/0253929 (2007-11-01), Cox, III
patent: 2008/0076706 (2008-03-01), Cox
patent: 2008/0219950 (2008-09-01), Cox
patent: 2008/0317713 (2008-12-01), Cox
patent: 2009/0060863 (2009-03-01), Cox
patent: 2066370 (1996-04-01), None
patent: 2287521 (1998-10-01), None
patent: 0185459 (1986-06-01), None
patent: 0243153 (1987-10-01), None
patent: 0312358 (1989-04-01), None
patent: 0355460 (1990-02-01), None
patent: 0458064 (1991-11-01), None
patent: 0612846 (1994-08-01), None
patent: 0668354 (1995-08-01), None
patent: 02-234692 (1990-09-01), None
patent: 04-164098 (1992-09-01), None
patent: 4-507099 (1992-12-01), None
patent: 5-268983 (1993-10-01), None
patent: 6-510904 (1994-12-01), None
patent: 9-503396 (1997-04-01), None
patent: 10-507080 (1998-07-01), None
patent: WO 86/05804 (1986-10-01), None
patent: WO 87/01132 (1987-02-01), None
patent: WO 90/12874 (1990-11-01), None
patent: WO 90/13310 (1990-11-01), None
patent: WO 93/00109 (1993-01-01), None
patent: WO 93/06217 (1993-04-01), None
patent: WO 94/01453 (1994-01-01), None
patent: WO 94/12219 (1994-06-01), None
patent: WO 94/12638 (1994-06-01), None
patent: WO 94/12639 (1994-06-01), None
patent: WO 94/22466 (1994-10-01), None
patent: WO 95/11987 (1995-05-01), None
patent: WO 95/32003 (1995-11-01), None
patent: WO 95/034326 (1995-12-01), None
patent: WO 96/04385 (1996-02-01), None
patent: WO 96/11949 (1996-04-01), None
patent: WO 96/31537 (1996-10-01), None
patent: WO 96/36362 (1996-11-01), None
patent: WO 97/11370 (1997-03-01), None
patent: WO 98/25971 (1998-06-01), None
patent: WO 98/37200 (1998-08-01), None
patent: WO 99/03887 (1999-01-01), None
patent: WO 00/42175 (2000-07-01), None
patent: WO 01/87925 (2001-11-01), None
patent: WO 02/44717 (2002-06-01), None
Walter M.R. et al. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature. 2000. vol. 376, p. 230-235.
Watson JD-Molecular Biology of the gene, third edition, WA Benjamin, eds. ISBN 0-8053-9609-8, p. 367, 1977.
U.S. Appl. No. 12/001,639, filed Dec. 11, 2007, Rosendahl et al.
U.S. Appl. No. 12/391,896, filed Feb. 24, 2009, Cox.
U.S. Appl. No. 12/502,839, filed Jul. 14, 2009, Cox et al.
U.S. Appl. No. 12/604,165, filed Oct. 22, 2009, Cox.
Abdel-Meguide et al., “Three dimensional structure of a genetically engineered variant of porcine growth hormone”, 1987, PNAS, vol. 84, pp. 6434-6437.
Alberts et ai, The birth, assembly and death of proteins. Chapter 5 in Molecular biology of the cell, Third edition, Garland Publishing, Inc. New York, NY, 1994; ISBN 0-8153-1619-4.
Barton et al., “Identification of Three Distinct Receptor Binding Sites of Murine Interleukin-11” The Journal of Biological Chemistry, vol. 274 No. 9, pp. 5755-5761 (Feb. 1999).
Bazan et al., “Unraveling the Structure of IL-2” Science, vol. 257 No. 5068, pp. 410-413 (Jul. 1992).
Bazan, “Haemopoietic receptors and helical cytokines” Immunology Today, 11:350-354 (1990).
Beilharz et al., “Antiviral and Antiproliferative Activities of Interferon-α1: The Role of Cysteine Residues” J. Interferon Res., 6:677-685 (1986).
Bill et al., “Expression and mutagenesis of recombinant human and murine erythropoietins inEscherichia coli” Biochimica et Biophysica Acta, 1261: 34-43 (1995).
Bittorf et al., “Structural and functional characterisation of recombinant human erythropoietin analogues” Febs. Lett., 366: 133-136 (1993).
Black RJ, “Animal Studies of Prophylaxis” Am. J. Med. 102 39-44 (1997).
Boissel et al., “Erythropoietin Structure-Function Relationships” J. Biol. Chem., 268(21):15983-15993 (1993).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions” Science, vol. 247 No. 4948, pp. 1306-1310 (Mar. 1990).
Campbell et al., “Pegylated peptides V” J. Peptide Res., 49:527-537 (1997).
Cantrell et al., “Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.” Proceedings of the National Academy of Sciences, USA, vol. 82 No. 18, pp. 6250-6254 (1985).
Cheetham et al., “NMR structure of human erythropoietin and a comparison with its receptor bound conformation” Nat. Structural Biol., 5: 861-866 (1998).
Cheetham et al., “Structure-function st

Affiliated with

Also associated with

Rating

Methods of use of G-CSF cysteine muteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of use of G-CSF cysteine muteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of use of G-CSF cysteine muteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2645239